|
|
|
| Brand | Other Names | Presentation | Strengths | Enquire |
| Antabuse ® | disulfiram | Effervescent Tablets | 200 mg x 30 |
| TGA indication | |
| ANTABUSE tablets are indicated to act as a deterrent to alcohol consumption and an aid in the overall management of selected chronic alcoholic patients involved in an integrated programme of counselling and psychiatry. Only alcoholic patients who are motivated to abstain from drinking and who are undergoing supportive psychotherapeutic treatment, ancillary to a total programme of rehabilitation, should be selected for ANTABUSE administration. | |
| PBS listing | |
| This product is not listed on the PBS. | |
| Information for Patients | |
| Consumer Medicine Information | |
| Relapse Prevention | Relapse Prevention.pdf |
| Information for Healthcare Professionals | |
| Product Information | Antabuse_PI.pdf |
| AUDIT Test | AUDIT test.pdf |
| FAST test | FAST test.pdf |
